DK1150680T3 - Anvendelse af moxonidin til behandling efter hjerteinfarkt - Google Patents

Anvendelse af moxonidin til behandling efter hjerteinfarkt

Info

Publication number
DK1150680T3
DK1150680T3 DK00902638T DK00902638T DK1150680T3 DK 1150680 T3 DK1150680 T3 DK 1150680T3 DK 00902638 T DK00902638 T DK 00902638T DK 00902638 T DK00902638 T DK 00902638T DK 1150680 T3 DK1150680 T3 DK 1150680T3
Authority
DK
Denmark
Prior art keywords
moxonidine
myocardial infarction
infarction
myocardial
physiologically compatible
Prior art date
Application number
DK00902638T
Other languages
English (en)
Inventor
Regina Gertruida Schoemaker
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Application granted granted Critical
Publication of DK1150680T3 publication Critical patent/DK1150680T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Details Of Spanners, Wrenches, And Screw Drivers And Accessories (AREA)
  • Heat Treatment Of Articles (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
DK00902638T 1999-02-01 2000-01-28 Anvendelse af moxonidin til behandling efter hjerteinfarkt DK1150680T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19903780 1999-02-01
EP00902638A EP1150680B1 (de) 1999-02-01 2000-01-28 Verwendung von moxonidin zur behandlung nach herzinfarkt
PCT/EP2000/000655 WO2000045820A1 (de) 1999-02-01 2000-01-28 Verwendung von moxonidin zur behandlung nach herzinfarkt

Publications (1)

Publication Number Publication Date
DK1150680T3 true DK1150680T3 (da) 2005-03-07

Family

ID=7895940

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00902638T DK1150680T3 (da) 1999-02-01 2000-01-28 Anvendelse af moxonidin til behandling efter hjerteinfarkt

Country Status (26)

Country Link
US (1) US7041303B2 (da)
EP (1) EP1150680B1 (da)
JP (1) JP4686027B2 (da)
KR (1) KR20010092793A (da)
CN (1) CN1166363C (da)
AT (1) ATE286731T1 (da)
AU (1) AU774855B2 (da)
BR (1) BR0007894A (da)
CA (1) CA2361600C (da)
CZ (1) CZ20012615A3 (da)
DE (2) DE10003771A1 (da)
DK (1) DK1150680T3 (da)
ES (1) ES2235829T3 (da)
HK (1) HK1042650B (da)
HU (1) HUP0105210A3 (da)
IL (1) IL144621A (da)
NO (1) NO321061B1 (da)
NZ (1) NZ513869A (da)
PL (1) PL195124B1 (da)
PT (1) PT1150680E (da)
RU (1) RU2261097C2 (da)
SK (1) SK10082001A3 (da)
TR (1) TR200102221T2 (da)
UA (1) UA67822C2 (da)
WO (1) WO2000045820A1 (da)
ZA (1) ZA200105827B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102850331B (zh) * 2012-09-17 2015-05-20 符爱清 一种化合物的制备方法
CN103483268B (zh) * 2013-09-17 2015-10-14 常州大学 一种4,6-二氯-2-甲基-5-硝基嘧啶的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739779A1 (de) * 1987-11-24 1989-06-08 Beiersdorf Ag Pharmazeutische praeparate
AU3233197A (en) * 1996-06-06 1998-01-05 Eli Lilly And Company Formulation and method for treating congestive heart failure

Also Published As

Publication number Publication date
KR20010092793A (ko) 2001-10-26
AU2440400A (en) 2000-08-25
DE50009220D1 (de) 2005-02-17
HUP0105210A2 (hu) 2002-05-29
IL144621A (en) 2004-12-15
UA67822C2 (uk) 2004-07-15
ZA200105827B (en) 2002-07-16
IL144621A0 (en) 2002-05-23
NZ513869A (en) 2001-09-28
EP1150680B1 (de) 2005-01-12
ES2235829T3 (es) 2005-07-16
HK1042650A1 (en) 2002-08-23
WO2000045820A1 (de) 2000-08-10
PL350559A1 (en) 2002-12-16
NO321061B1 (no) 2006-03-06
JP2002536334A (ja) 2002-10-29
CN1338938A (zh) 2002-03-06
CA2361600A1 (en) 2000-08-10
TR200102221T2 (tr) 2002-01-21
HK1042650B (zh) 2005-05-06
NO20013753L (no) 2001-09-28
DE10003771A1 (de) 2000-08-03
PT1150680E (pt) 2005-03-31
SK10082001A3 (sk) 2002-04-04
EP1150680A1 (de) 2001-11-07
RU2261097C2 (ru) 2005-09-27
US20020045633A1 (en) 2002-04-18
PL195124B1 (pl) 2007-08-31
AU774855B2 (en) 2004-07-08
CA2361600C (en) 2008-08-26
HUP0105210A3 (en) 2003-01-28
CN1166363C (zh) 2004-09-15
BR0007894A (pt) 2001-10-30
ATE286731T1 (de) 2005-01-15
JP4686027B2 (ja) 2011-05-18
CZ20012615A3 (cs) 2002-01-16
NO20013753D0 (no) 2001-07-31
US7041303B2 (en) 2006-05-09

Similar Documents

Publication Publication Date Title
RS50876B (sr) Upotreba flibanserina u lečenju seksualnih poremećaja
BR0315337A (pt) Composto, formulação farmacêutica, e, método para tratar câncer
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
BR0108452A (pt) Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva
YU48099A (sh) Kompozicija koja obuhvata hranljivi materijal i biljku i njena upotreba
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
SG156681A1 (en) Use of ranolazine in combination with at least one remodeling agent for reversing left ventricular remodeling in the treatment of heart failure
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
ATE451934T1 (de) Pharmazeutische zusammensetzung zur behandlung von rhinitiden
DE60025698D1 (de) Neue dialysemethode
TR199701121T1 (xx) Benazepril veya benazeprilat ve valsartan i�eren kombinasyon bile�imleri.
DK1150680T3 (da) Anvendelse af moxonidin til behandling efter hjerteinfarkt
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
RU2005129591A (ru) Способ лечения хронической сердечной недостаточности
BR0303384A (pt) Citalopram e seus usos no tratamento de pressão sanguìnea elevada
DE60235965D1 (de) Kombination aus levosimendan und einer kalziumquelle zur behandlung von herzinsuffizienz
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
PT1305020E (pt) Utilizacao de fibratos para a preparacao de um medicamento util no tratamento da insuficiencia cardiaca congestiva
RU96102110A (ru) Способ профилактики и лечения изъязвлений роговицы
BR9913242A (pt) Uso de r(+)-alfa-(2,3-dimetoxifenil)-1-[2-(4-fluorofenil)etil]-4-p iperidinametanol para o tratamento de desordens de sono
AR022475A1 (es) Metodo para la prevencion o reduccion de eventos cardiovasculares asociados con intervencion coronaria.
UA6306U (en) Method for treating disorders of hepatic blood circulation in patients with arterial hypertension and heart failure
RU2000105080A (ru) Препарат для лечения гриппа
UA40334A (uk) Спосіб корекції фетоплацентарної недостатності у юних та пізніх першороділь
RU99101298A (ru) Гомеопатическое средство для лечения сердечной недостаточности